Redo aortic valve replacement in children

Kirk R Kanter1, Paul M Kirshbom, Brian E Kogon

  • 1Division of Cardio-Thoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA. kkanter@emory.edu

Insights

Redo aortic valve replacement (AVR) in children is feasible with acceptable outcomes, though repeat reoperations increase risk. Early referral is crucial to prevent ventricular dysfunction and improve results for pediatric cardiac surgery patients.

Area of Science:

  • Pediatric Cardiac Surgery
  • Congenital Heart Disease Management
  • Cardiovascular Therapeutics

Background:

  • A subset of children undergoing aortic valve replacement (AVR) require subsequent valve re-replacement (redo-AVR).
  • This study analyzes outcomes from 38 redo-AVRs performed on 30 pediatric patients.

Purpose of the Study:

  • To evaluate the safety and efficacy of redo-AVR in a pediatric population.
  • To identify factors influencing outcomes in children requiring repeat aortic valve surgery.

Main Methods:

  • Retrospective analysis of 38 redo-AVRs in 30 children (age 2 months–20 years).
  • Indications included stenosis, regurgitation, endocarditis, thrombosis, and aneurysm.
  • Surgical techniques involved prosthesis implantation, often with annulus enlargement (Konno, Manougian procedures).

Main Results:

  • Most redo-AVRs used mechanical prostheses; 71% involved annulus enlargement.
  • Upsizing the valve prosthesis was common (25 valves, median increase 4 mm).
  • Hospital mortality was higher in second or third redo-AVRs; the only death in first redo-AVR patients was in cardiogenic shock.

Conclusions:

  • Redo-AVR in children can be achieved with manageable morbidity and mortality.
  • Larger valve prostheses can be successfully implanted during redo-AVR.
  • Second or third redo-AVRs carry higher risks, underscoring the need for early referral before ventricular dysfunction develops.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...